Joseph Valentino -

h-index

Resultados de investigaciones por año

Experiencia relacionada con los ODS de las Naciones Unidas

En 2015, los estados miembros de las Naciones Unidas acordaron 17 Objetivos de Desarrollo Sostenible (ODS) para erradicar la pobreza, proteger el planeta y garantizar la prosperidad para todos. El trabajo de esta persona contribuye al logro de los siguientes ODS:

Cuantificación de educación / académica

Post Doctoral Fellow, University Of Iowa

1993

Master of Science, University Of Minnesota

1992

Residency, University Of Minnesota

1992

Internship, University of Medicine and Dentistry of New Jersey

1988

Doctor of Medicine, University of Medicine and Dentistry of New Jersey

1987

Bachelor of Science, Lehigh University

1981

Huella digital

Profundizar en los temas de investigación en los que Joseph Valentino está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.

1 Perfiles similares

6 Activo
10 Terminado

24-HN-41-RMI (ASP-1929-381): A Phase 3 Multicenter, Randomized, Double-arm, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With
Valentino, J. (PI)
Rakuten Medical Incorporated
12/5/24 → 12/5/26
Proyecto: Research project
Multi-35 Sub-Study B: Phase 1b/2 Subprotocol of ASP-1929 Photoimmunotherapy in Combination with anti-PD1 Therapy in Patients with Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
Valentino, J. (PI)
Rakuten Medical Incorporated
11/10/20 → 5/15/26
Proyecto: Research project
Multi-35 Sub-Study C: A Phase 1b/2 Substudy of ASP-1929 Photoimmunotherapy in Combination with Anti-PD1 Therapy in Patients with Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma Who Have Progressed on Anti-PD1 Therapy
Valentino, J. (PI)
Rakuten Medical Incorporated
11/10/20 → 5/15/26
Proyecto: Research project
Multi-35 Sub-Study A: Phase 1b/2 Subprotocol of ASP-1929 Photoimmunotherapy in Combination with anti-PD1 Therapy in Patients with Head and Neck Squamous Cell Carcinoma
Valentino, J. (PI)
Rakuten Medical Incorporated
11/10/20 → 5/15/26
Proyecto: Research project
A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma
Valentino, J. (PI)
Rakuten Medical Incorporated
12/11/19 → 1/3/26
Proyecto: Research project

66 Article
3 Review article
1 Comment/debate
1 Short survey

Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial
the INSPIRE Trial Clinical Investigators, mar 2025, En: Oral Oncology Reports. 13, 100706.
Producción científica: Article › revisión exhaustiva

Acceso abierto
Rural and Appalachian cancer survivors’ responses to tobacco use screening and tobacco treatment offer
Feather, A. R., Shelton, B. J., Blair, C., Davis, D. B., Scales, J., Darville, A., Valentino, J., McLouth, L. E. & Burris, J. L., sept 2025, En: Tobacco Induced Diseases. 23, 123.
Producción científica: Article › revisión exhaustiva

Acceso abierto
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Cognetti, D. M., Curry, J. M., Johnson, J., Kwon, M., Su, S. Y., Civantos, F., Olazagasti, C., Valentino, J., Arnold, S., Bell, R. B., Gibson, M. K., Mannion, K., Van Abel, K. M., Price, K. A., Dong, H., Thorne, A. H., Suzuki, T. & Gillenwater, A. M., 2025, (Accepted/In press) En: Head and Neck.
Producción científica: Article › revisión exhaustiva

Acceso abierto
NSD3::NUTM1 Fusion Sarcoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Prolonged Survival
Di, J., Alhaidary, A. M., Wang, C., Liu, J., Wei, S., Valentino, J. & Bocklage, T. J., ago 2024, En: Biomedicines. 12, 8, 1709.
Producción científica: Article › revisión exhaustiva

Acceso abierto
2 Citas (Scopus)
Copy Number Variation That Influences the Ionizing Radiation Sensitivity of Oral Squamous Cell Carcinoma
Izumi, T., Rychahou, P., Chen, L., Smith, M. H. & Valentino, J., oct 2023, En: Cells. 12, 20, 2425.
Producción científica: Article › revisión exhaustiva

Acceso abierto
2 Citas (Scopus)

Joseph Valentino, MD

Perfil personal

Experiencia relacionada con los ODS de las Naciones Unidas

Cuantificación de educación / académica

Huella digital

Colaboraciones y áreas de investigación principales de los últimos cinco años

Ver detalles

24-HN-41-RMI (ASP-1929-381): A Phase 3 Multicenter, Randomized, Double-arm, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With

Multi-35 Sub-Study B: Phase 1b/2 Subprotocol of ASP-1929 Photoimmunotherapy in Combination with anti-PD1 Therapy in Patients with Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma

Multi-35 Sub-Study C: A Phase 1b/2 Substudy of ASP-1929 Photoimmunotherapy in Combination with Anti-PD1 Therapy in Patients with Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma Who Have Progressed on Anti-PD1 Therapy

Multi-35 Sub-Study A: Phase 1b/2 Subprotocol of ASP-1929 Photoimmunotherapy in Combination with anti-PD1 Therapy in Patients with Head and Neck Squamous Cell Carcinoma

A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician's Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma

Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial

Rural and Appalachian cancer survivors’ responses to tobacco use screening and tobacco treatment offer

Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

NSD3::NUTM1 Fusion Sarcoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Prolonged Survival

Copy Number Variation That Influences the Ionizing Radiation Sensitivity of Oral Squamous Cell Carcinoma

Joseph Valentino, MD

Perfil personal

Experiencia relacionada con los ODS de las Naciones Unidas

Cuantificación de educación / académica

Huella digital

Colaboraciones y áreas de investigación principales de los últimos cinco años

Proyectos

Producción científica